We investigated digital information channels used by midwives, highlight sources and levels of awareness they have of new products. We recommended semi-ethnographic interviews and eye-tracking to test digital concepts in everyday context, and allow a user digital journey to be mapped in as realistic environment as possible so behaviour could be fully understood among all the stimulus and distractions of the actual workplace.
Product concept test for a pre-formulated botulinum toxin to assess benefits and how it might impact the treatment landscape in the clinic, and among home treating professionals. We conducted a series of semi-ethnographic interviews with target users, to map current practice across the health professional target groups and assessed the impact on current practice for a pre-formulated product.
This project set out to examine haematologists’ needs in cellular analysis solutions and explore the analyser type, design, and current and future expected lab requirements and test parameters across haematology, morphology and flow cytometry. Walk throughs in the laboratory allowed use to understand the complexities of demands placed on lab design and to enable the client to adapt design plans to accommodate actual day-to-day lab design requirements.
With the increasing use of biologics across indications demand for new devices that meet varied patient needs is growing. Through semi-ethnographic interviews with patients and nurses we were able to understand current device usage and evaluate behaviour when using prototype designs; delivering for the client a clear recommendation on which designs should be taken into development and the drivers around which to build a coherent marketing strategy.
To examine the relationship and care management between Alzeihmer’s patients and their carers we undertook a series of ethnographic interviews across the UK. Looking at all sides of the debate, we interviewed nurses, neurologists, carers and caring relatives and drafted a patient management and treatment framework from which to explore the options for a injectable medication for Alzheimer’s disease.
